[Heart transplantation at the Institute of Clinical and Experimental Medicine in Prague].
In the Institute of Clinical and Experimental Medicine in Prague 101 orthotopic allotransplantations of the heart were performed in 100 patients (87 men and 13 women). The reason for transplantation were terminal stages in the first place dilated cardiomyopathies and ischaemic heart disease. 58% of the patients survive after transplantation, the mortality rate is 42%. The highest mortality is in the early postoperative period (within two weeks after operation)--21 cases (50%). The longest survival period is nine years and six months. All patients have cyclosporin immunosuppressive treatment (in combination with another drug, later with another two drugs). In the authors' group in particular incipient acute rejections are encountered, "mild" rejections are less frequent and "moderate" rejections least frequent. The patients do not reach the stage of advanced acute rejection, i.e. "severe" rejection. Acute rejections are treated as a rule with 3 g Urbason. After this treatment acute rejection improves as a rule completely after one or two weeks therapy.
Urbanová
D
D
Patologicko-anatomické pracovistĕ, Institut klinické a experimentální medicíny, Praha.
Málek
I
I
Gebauerová
M
M
Stanĕk
V
V
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D018153:Czech Republic / Q000453:epidemiology; D005260:Female; D006084:Graft Rejection; D016027:Heart Transplantation / Q000401:mortality; D006801:Humans; D008297:Male; D008875:Middle Aged
Transplantace srdce v Institutu klinické a experimentální medicíny v Praze.